Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Matawan, New Jersey
- Most recent report
- 8-K, filed Sep 29, 2026
- Incorporated
- Delaware
- Filings on record
- 125 filings
- On EDGAR
- CIK 1894525
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8
News 8 of 26
Prospectuses and Registrations 8 of 14
- S-8 Registration statement for an employee plan May 23, 2025
- 424B4 Final prospectus for an offering May 9, 2025
- POS AM Post-effective amendment to a registration May 2, 2025
- POS AM Post-effective amendment to a registration May 1, 2025
- POS AM Post-effective amendment to a registration Apr 17, 2025
- FWP Free writing prospectus Feb 10, 2025
- S-1/A Registration statement for an offering, amended Feb 10, 2025
- S-1/A Registration statement for an offering, amended Feb 6, 2025
Ownership 8 of 41
- SCHEDULE 13D/A Large holder reported an active stake, amended May 7, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 30, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Mar 20, 2026
- SCHEDULE 13G Large holder reported a passive stake Feb 11, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jan 26, 2026
- 4/A Insider reported a trade, amended Nov 21, 2025
- 4 Insider reported a trade Nov 13, 2025
- 4 Insider reported a trade Nov 13, 2025
Other 8 of 36
Everything here comes from Apimeds Pharmaceuticals US, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.